GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (STU:PHF) » Definitions » YoY EBITDA Growth

Equasens (STU:PHF) YoY EBITDA Growth : 12.74% (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Equasens YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Equasens's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 12.74%.

Equasens's EBITDA per Share for the six months ended in Jun. 2023 was €2.27.


Equasens YoY EBITDA Growth Historical Data

The historical data trend for Equasens's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equasens YoY EBITDA Growth Chart

Equasens Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.75 9.65 15.56 7.24 -100.00

Equasens Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.16 -1.13 14.99 12.74 -100.00

Equasens YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Equasens's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(4.548-4.241)/ | 4.241 |
=7.24 %

Equasens's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(2.274-2.017)/ | 2.017 |
=12.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Equasens YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Equasens's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Equasens (STU:PHF) Business Description

Traded in Other Exchanges
Address
5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.

Equasens (STU:PHF) Headlines

From GuruFocus

Bulldog Investors Sniffs Out Value in the Pacholder High Yield Fund

By Kyle Ferguson Kyle Ferguson 04-14-2017